Comment on: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance"
Appl Health Econ Health Policy
.
2020 Jun;18(3):457-458.
doi: 10.1007/s40258-020-00574-9.
Author
J P Hays
1
Affiliation
1
Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre (Erasmus MC), Rotterdam, The Netherlands. j.hays@erasmusmc.nl.
PMID:
32201932
DOI:
10.1007/s40258-020-00574-9
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents*
Drug Resistance, Bacterial / drug effects*
Humans
Patient Preference
Substances
Anti-Bacterial Agents